RAD stock opened lower by 3% at $9.66 in Wednesday’s trading session after Rite Aid (NYSE:RAD) announced that it will increase the minimum age requirement to buy tobacco products to 21 within the next three ... [Read]
Fulcrum and Autopro are expected to bring C$35 million in revenue and C$5.5 million in EBITDA to mCloud on trailing twelve-month basis Makes mCloud a leading provider of disruptive AI, 3D, and cloud computing solutions to the oil and ... [Read]
Akari Therapeutics (NASDAQ:AKTX) is making headlines after the biopharmaceutical company announced positive data from a Phase 2 clinical trial. The news, released today, sent AKTX stock up nearly 20% at the time of writing. AKTX ... [Read]
ASNA stock took a dive again as Ascena Retail Group (NASDAQ:ASNA), apparel retailer, continues to struggle. Although there was no company-specific bad news that could have led to the drop in stock price, it dipped ... [Read]
On the hunt for penny stocks? April has delivered us some significant climbers and now that we are over halfway through the month, looking ahead at what will happen come May is important. In this ... [Read]
Vancouver, British Columbia, April 23, 2019 — CannaOne Technologies (CSE:CNNA) (FRA: 3CT) (“CannaOne” or the “Company”) is pleased to provide details of the partnership previously announced with Real Health Science last month. On April 15, 2019, ... [Read]
Moleculin Biotech (NASDAQ:MBRX) has got investors on the edge of their seats. On Monday, April 22, the company said it made a “significant discovery” for lung cancer and will be discussing it on a conference ... [Read]
Arcimoto stock was driven higher in February when Arcimoto Inc (NASDAQ:FUV) showed it had 3,018 pre-orders for its unique three-wheeled electric vehicle. At its peak, FUV stock spiked to $7.10 on the NASDAQ exchange on February ... [Read]
GOGO stock has been showing solid momentum over the past week following Gogo Inc’s (NASDAQ:GOGO) announcement of preliminary financial results. Although GOGO stock has been trading well beyond its all-time high, it could face some ... [Read]
What an incredible two days it has been for Mustang Bio (NASDAQ:MBIO). On Wednesday, April 17, the company announced that it entered a licensing agreement with St. Jude Children’s Research Hospital to develop the lentiviral ... [Read]